This week, Nsight Health is on the ground in Atlanta as an exhibitor and speaker at the 2026 Renal Physicians Association Annual Meeting (RPA 2026), one of the most important gatherings for nephrology professionals in the country. From April 16 through April 19, our team is meeting with nephrologists, practice administrators, and care delivery leaders to discuss how fully managed remote care is transforming outcomes for patients with chronic kidney disease.
If you are attending RPA 2026, stop by Booth #609 to meet the team and see firsthand how Nsight Health operationalizes Remote Patient Monitoring (RPM), Chronic Care Management (CCM), and all six CMS-reimbursed remote care programs for nephrology practices.
Today at 10:40 AM, Nsight Health's Head of Sales Alex Bienemann joined Ron Reynolds, Practice Manager at CSRA Renal Services, to present "The RPM CCM Nephrology Opportunity" to a room of nephrologists and renal care leaders.
The session explored how nephrology practices can leverage RPM and CCM to improve clinical outcomes for CKD patients while building sustainable revenue streams through Medicare's care management reimbursement framework. Ron Reynolds brought the provider perspective, sharing how CSRA Renal Services has integrated remote monitoring into its care delivery model and what that integration looks like operationally for a busy nephrology practice.
Ron Reynolds, Practice Manager at CSRA Renal Services, presenting on the RPM and CCM opportunity for nephrology practices at RPA 2026.
"Nephrology practices are sitting on one of the largest untapped opportunities in remote care," said Alex Bienemann. "CKD patients require continuous monitoring between visits. Blood pressure management alone can change the trajectory of disease progression. When you pair RPM with CCM under a fully managed model, you get better outcomes for patients and a meaningful revenue stream for the practice without adding staff or complexity."
Alex Bienemann, Head of Sales at Nsight Health, presenting alongside the Nsight clinical evidence platform at RPA 2026.
The presentation drew on real-world clinical evidence from Nsight Health's monitored patient population, including observed blood pressure reductions among CKD patients enrolled in RPM programs. These data points reinforce what the nephrology community increasingly recognizes: that proactive, between-visit monitoring can meaningfully impact the management of hypertension, one of the primary accelerators of kidney disease progression.
Chronic kidney disease affects an estimated 37 million Americans, and the vast majority of those patients also live with hypertension, diabetes, or both. These are precisely the conditions that benefit most from continuous remote monitoring and structured care coordination.
For nephrology practices specifically, the clinical case for RPM and CCM is compelling:
Our team of ten, including four dedicated booth staff, is demonstrating Nsight Health's fully managed remote care platform throughout the conference. Visitors to Booth #609 can see:
The Nsight Health team engaging with nephrology professionals at Booth #609, with the Nsight Health platform and Tenovi devices on display.
Attendees at the Nsight Health booth during RPA 2026, with the "RPM and CCM Built for Nephrology Practices" display visible.
The Nsight Health team connecting with renal care leaders on the RPA 2026 exhibit floor in Atlanta.
RPA 2026 represents a strategic investment in Nsight Health's growing presence in the nephrology space. As one of the fastest-growing remote care companies in the country, recently ranked No. 12 on the 2026 Inc. Regionals: Southeast with 683% two-year revenue growth, Nsight Health is expanding into specialty verticals where remote monitoring has the highest clinical impact.
Nephrology is at the top of that list. The combination of high patient acuity, multi-condition complexity, Medicare coverage, and a pressing need for between-visit monitoring makes renal care one of the most natural applications for a fully managed RPM and CCM program.
Our presence at RPA 2026, as both an exhibitor and a speaker alongside an active nephrology practice partner, reflects Nsight Health's commitment to building long-term relationships in the nephrology community. This is not a one-time conference activation. It is the beginning of a sustained investment in understanding and serving the unique clinical and operational needs of renal care teams.
Nsight Health is not a software platform. We are a fully managed remote care company that provides the clinical staff, devices, documentation, and billing infrastructure to operationalize all six CMS-reimbursed programs: RPM, CCM, PCM, BHI, CoCM, and RTM.
Our W2 clinical team currently supports 130,000+ patients across 1,700+ provider teams and 480+ clinics, with more than 40 million vital sign readings collected and analyzed. Every patient has a named care coordinator, a personalized care plan, and access to 24/7 clinical monitoring by licensed clinicians based in the United States.
For nephrology practices, this means your team can focus on in-office patient care while Nsight Health handles the between-visit monitoring, care coordination, documentation, and billing across every program your patients qualify for.
The Nsight Health team at Booth #609, RPA 2026 in Atlanta.
If you are attending RPA 2026 in Atlanta, visit us at Booth #609 to meet the team, see the platform, and discuss how Nsight Health can help your nephrology practice deliver better outcomes while capturing the full value of remote care reimbursement.
Not at the conference? Schedule a demo to learn how Nsight Health can operationalize RPM, CCM, and all six CMS programs for your practice.
Nsight Health is a fully managed remote care company delivering RPM, CCM, PCM, BHI, CoCM, and RTM with 24/7 W2 clinician support for 130,000+ patients across 1,700+ provider teams. Nsight Health is headquartered in Miami, Florida, and was recently named No. 12 on the 2026 Inc. Regionals: Southeast list with 683% two-year revenue growth. For more information, visit nsightcare.com.
Clinical outcomes data referenced herein reflects internal observations from Nsight Health's remote patient monitoring programs and has not been independently validated through peer-reviewed clinical trials. Individual patient outcomes vary based on condition severity, medication adherence, patient engagement, and other clinical factors. Nothing in this article constitutes medical advice or a guarantee of clinical outcomes.